BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-20.29M |
| Operating Margin | 0.00% |
| Return on Equity | -495.60% |
| Return on Assets | -195.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.01 |
| Price-to-Book | 44.59 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.00 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $55.51M |
| Float | $46.84M |
| % Insiders | 14.05% |
| % Institutions | 9.27% |
Volatility is currently expanding
Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.
Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home.
HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2026 Results.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time.
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Closing of $10 Million Public Offering of Common Stock.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BEAT and any ticker you trade — then tracks every position and per-strategy win rate.
